Wegovy Tablets: Everything You Need to Know About the New Oral Weight Loss Treatment
The world of weight management is evolving rapidly, and one of the most anticipated developments is the arrival of Wegovy tablets.

For many people, the biggest barrier to starting GLP-1 treatment isn't the medication itself, it's the thought of administering a weekly injection. The introduction of an oral version of Wegovy could provide an alternative option for patients who would prefer a tablet rather than an injection.

Who Might Benefit Most From Wegovy Tablets?
Wegovy tablets may appeal to patients who:

• Are uncomfortable with injections
• Prefer taking medication orally
• Travel frequently
• Want a needle-free treatment option
• Have delayed starting treatment because of concerns about injections
• For many patients, the availability of a tablet may remove one of the biggest psychological barriers to beginning treatment.

Can I swap to tablets from Wegovy or Mounjaro injections?
If you are currently using an injectable treatment and are considering switching to Wegovy Tablets, please follow the guidance provided on our website. If you are unsure whether switching is right for you, we recommend booking a consultation with one of our prescribers to discuss your options and ensure any transition is made safely and appropriately.

The Future of Weight Management
The approval of Wegovy tablets represents a significant milestone in obesity treatment. For the first time, patients may have access to an oral GLP-1 medicine specifically developed for weight management rather than requiring weekly injections. Recent approvals and regulatory decisions suggest the tablet will play an increasingly important role in obesity management over the coming years.

Wegovy tablets contain the same active ingredient as Wegovy injections and have demonstrated impressive weight loss results in large clinical trials. Patients achieved average weight loss of approximately 13.6% to 16.6% of their starting body weight depending on treatment adherence, with many achieving substantially greater reductions. 

While injections remain an excellent option for many patients, the arrival of a tablet formulation could make GLP-1 treatment accessible to a wider range of people who would prefer a needle-free approach to weight management.

As always, the most appropriate treatment depends on your individual circumstances, medical history and preferences. Speaking with a qualified healthcare professional remains the best way to determine which option may be right for you.

Unlike the weekly injection, Wegovy tablets are taken once daily.

To maximise absorption, patients are generally advised to:

1. Take the tablet first thing in the morning
2. Take it on an empty stomach
3. Swallow with a small amount of water
4. Wait at least 30 minutes before eating, drinking or taking other medications
5. This is because semaglutide is absorbed differently when taken orally and requires specific conditions to achieve consistent blood levels.

Active ingredient: Semaglutide

Other ingredients: salcaprozate sodium (SNAC) and magnesium stearate.

For the most up-to-date list of ingredients, please check the Patient Information Leaflet inside the box.

The side effect profile of oral semaglutide is very similar to injectable semaglutide.

The most commonly reported side effects include:

• Nausea
• Vomiting
• Diarrhoea
• Constipation
• Abdominal discomfort
• Indigestion

These side effects are generally mild to moderate and often improve as the body adjusts to treatment. Gastrointestinal side effects remain the most frequently reported adverse events.

Please read the following warnings carefully before use.

• Do not use Wegovy if you, or any of your family, have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
• Do not use Wegovy if you have had a serious allergic reaction to semaglutide or any of the ingredients in Wegovy tablets.
• Wegovy may cause thyroid tumours, including cancer. Tell your healthcare professional if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.

This treatment may not be suitable for all patients, including some older adults or those with complex health conditions.

For a full list of warnings and side effects, please see the Patient Information Leaflet.

Download patient information leaflet (PIL) on the link below:

https://www.medicines.org.uk/emc/files/pil.102344.pdf 

What is the difference between the Wegovy pill and the Wegovy injection?
Both Wegovy pill and Wegovy injections contain semaglutide, the same active ingredient used to support weight management.
The difference is how you take them. Wegovy injections are used once a week, while the Wegovy pill is taken once a day.
The good news? With more options available, you can choose the treatment that best fits your lifestyle and routine.

Is the Wegovy pill as effective as the injection?
You might expect a pill to be less effective than an injection, but clinical trials suggest that's not the case.
In studies, the Wegovy pill delivered weight loss results comparable to Wegovy injections, with similar numbers of people reaching 5%, 10%, 15% and 20% weight loss milestones.
That means you may be able to choose the format that fits your life, without compromising on outcomes.

What should I avoid while using Wegovy?
Small changes can make a big difference to how you feel on Wegovy. It's worth paying extra attention to what you're eating and drinking, especially when starting treatment or increasing your dose.

Try to limit:

• High fat, greasy food
• Caffeine
• Excessive alcohol
• Spicy foods
• High sugar food and drink

You should also tell your prescriber about any medicines you are taking, particularly:

• Other weight loss treatments
• Other GLP-1 medicines
• Insulin or medicines used to treat diabetes
• Warfarin